Literature DB >> 11735684

Estrogen replacement therapy and female athletes: current issues.

D C Cumming1, C E Cumming.   

Abstract

Physicians commonly recommend estrogen replacement as treatment for exercise-associated amenorrhoea. While the evidence shows that the basis of the amenorrhoea is estrogen deficiency, it is not clear that it is the only factor in the development of lowered bone density found in oligo-amenorrhoeic female athletes. Nutritional factors, significant in the development of the reproductive dysfunction, could also contribute to bone loss. No randomised, controlled studies of estrogen replacement in athletes have been published. However, one nonrandomised study of a small group of athletes does suggest that there are significant gains in bone density to be made by the initiation of estrogen therapy. More research is clearly needed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735684     DOI: 10.2165/00007256-200131150-00001

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  65 in total

Review 1.  The contribution of nutritional factors to osteopenia in the elderly.

Authors:  O Sahota; D J Hosking
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2001-01       Impact factor: 4.294

2.  Estrogen status and heredity are major determinants of premenopausal bone mass.

Authors:  R Armamento-Villareal; D T Villareal; L V Avioli; R Civitelli
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 3.  Disturbance of the reproductive axis induced by negative energy balance.

Authors:  S J Judd
Journal:  Reprod Fertil Dev       Date:  1998       Impact factor: 2.311

4.  Bone health is not affected by luteal phase abnormalities and decreased ovarian progesterone production in female runners.

Authors:  M J De Souza; B E Miller; L C Sequenzia; A A Luciano; S Ulreich; S Stier; K Prestwood; B L Lasley
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

5.  Increased cortisol production in women runners.

Authors:  A L Villanueva; C Schlosser; B Hopper; J H Liu; D I Hoffman; R W Rebar
Journal:  J Clin Endocrinol Metab       Date:  1986-07       Impact factor: 5.958

6.  Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy.

Authors:  D C Cumming
Journal:  Arch Intern Med       Date:  1996-10-28

7.  Reproductive function in women athletes.

Authors:  R W Rebar; D C Cumming
Journal:  JAMA       Date:  1981-10-02       Impact factor: 56.272

8.  The effect of amenorrhea on calcaneal bone density and total bone turnover in runners.

Authors:  V J Harber; C E Webber; J R Sutton; J D MacDougall
Journal:  Int J Sports Med       Date:  1991-10       Impact factor: 3.118

9.  Interrelationships of diet, athletic activity, menstrual status, and bone density in collegiate women.

Authors:  T Lloyd; J R Buchanan; S Bitzer; C J Waldman; C Myers; B G Ford
Journal:  Am J Clin Nutr       Date:  1987-10       Impact factor: 7.045

10.  Bone mineral density after resumption of menses in amenorrheic athletes.

Authors:  B L Drinkwater; K Nilson; S Ott; C H Chesnut
Journal:  JAMA       Date:  1986-07-18       Impact factor: 56.272

View more
  2 in total

Review 1.  Effects of estrogen replacement on metabolic factors that influence physical performance in female hypogonadism.

Authors:  W M Kohrt; R E Van Pelt; W S Gozansky
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

2.  Stress fractures of the foot and ankle in athletes.

Authors:  Stephanie W Mayer; Patrick W Joyner; Louis C Almekinders; Selene G Parekh
Journal:  Sports Health       Date:  2014-11       Impact factor: 3.843

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.